p53 expression in cytology samples may represent a marker of early-stage cancer
Policardo, Federica; Tralongo, Pietro; Arciuolo, Damiano; Fiorentino, Vincenzo; Cardasciani, Lina; Pierconti, Francesco; Carlino, Angela; Curatolo, Mariangela; Pontecorvi, Alfredo; Fadda, Guido; Crea, Carmela; Lombardi, Celestino Pio; Raffaelli, Marco; Larocca, Luigi Maria; Pantanowitz, Liron; Rossi, Esther Diana
2023-06
Citation
Policardo, Federica; Tralongo, Pietro; Arciuolo, Damiano; Fiorentino, Vincenzo; Cardasciani, Lina; Pierconti, Francesco; Carlino, Angela; Curatolo, Mariangela; Pontecorvi, Alfredo; Fadda, Guido; Crea, Carmela; Lombardi, Celestino Pio; Raffaelli, Marco; Larocca, Luigi Maria; Pantanowitz, Liron; Rossi, Esther Diana (2023). "p53 expression in cytology samples may represent a marker of early-stage cancer." Cancer Cytopathology 131(6): 392-401.
Abstract
BackgroundTP53 gene plays a major role in the negative control of cell proliferation and in the regulation of signaling cascades. TP53 mutation may have a relevant role in the malignant transformation of thyroid cells as well as thyroid tumor progression. TP53 mutation has been detected only in few well differentiated thyroid carcinomas and is absent in benign conditions.MethodsA total of 162 prospective thyroid cytology and corresponding histological samples diagnosed from atypia of indeterminate significance (AUS) to malignant, were studied via immunocytochemistry for p53. Hence, 50 benign lesions (B) were used as negative control. Molecular analysis for p53 only was performed.ResultsThe cytology resulted in 50 B, 48 AUS, 40 follicular neoplasms (FNs), 23 suspicious for malignancy (SFM), and 1 malignant (M) case. The authors reported 102 negative and 60 positive p53 cases. The 60 positive cases included 27 cases with weak and/or focal cytoplasmic positivity (+1) and 33 with cases moderate (2+) to strong (3+) cytoplasmic and/or nuclear expression. Overall, 71 cases had histology (2 B, 11 AUS, 37 FN, 20 SFM, and 1 M) including 61.7% benign and 38.2% malignant diagnoses. Only 16 of 71 (5 FN, 10 SFM, and 1 M) were p53-positive. Furthermore, 100% AUS and 86.5% FN cases were p53-negative, none of which had malignant histology. All p53-positive cases were associated with a larger nodule size, tall-cell variant subtype, multifocality, extra thyroidal infiltration, and nodal metastases. Noninvasive follicular thyroid neoplasm with papillary like nuclear features were negative for p53. Few discrepancies in p53 intensity were observed on histology; there were no differences with the molecular testing.Conclusionsp53 might be useful in discriminating thyroid follicular lesions. p53 is likely to be a useful diagnostic marker in recognizing indeterminate lesions that are well-differentiated thyroid cancers.p53 might be useful in discriminating thyroid follicular lesions. p53 is likely to be a useful diagnostic marker in recognizing indeterminate lesions that are well-differentiated thyroid cancers.Publisher
Wiley Periodicals, Inc. British Thyroid Association, Royal College of Physicians
ISSN
1934-662X 1934-6638
Other DOIs
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.